Adult Macular Degeneration
Showing 1 - 25 of >10,000
Neovascular Age Related Macular Degeneration Trial in France (RTH258/Brolucizumab)
Active, not recruiting
- Neovascular Age Related Macular Degeneration
-
Nice, Cedex1, France
- +39 more
Jan 20, 2023
Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion Trial in Sacramento (CD34+ bone
Enrolling by invitation
- Non-exudative Age-related Macular Degeneration
- +4 more
- CD34+ bone marrow stem cells intravitreal
-
Sacramento, CaliforniaUniversity of California Davis
Aug 8, 2022
Age-related Macular Degeneration Trial in Madison (QA102, Placebo)
Completed
- Age-related Macular Degeneration
- QA102
- Placebo
-
Madison, WisconsinCovance Clinical Research Unit Inc.
Dec 31, 2021
Best Disease and Other Retinal Degenerative Diseases.
Active, not recruiting
- Retinal Disease
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2022
Eye Diseases, Retinitis Pigmentosa, Glaucoma Trial in St. John's (AlloRx)
Recruiting
- Eye Diseases
- +6 more
- AlloRx
-
St. John's, Antigua and BarbudaMedical Surgical Associates Center
Jan 4, 2022
Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)
Not yet recruiting
- Age Related Macular Degeneration (AMD)
- SPIN
- Non-aerobic, stretching/balance intervention Control
-
Decatur, GeorgiaAtlanta VA Medical and Rehab Center, Decatur, GA
Jun 26, 2023
Data of Intravitreal Aflibercept Injection in Patients of Wet
Completed
- Wet Age-related Macular Degeneration
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, IndiaMany Locations
Feb 2, 2023
Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)
Completed
- Age-related Macular Degeneration
- Blood draw and urine collection
-
Coimbra, PortugalAIBILI
Jan 6, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),
Suspended
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Intravitreal injection of IBI302(dose 1)
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 17, 2023
Preparation of Patient Autologous Induced Pluripotent Stem
Not yet recruiting
- Age-Related Macular Degeneration
- somatic cell collection
- (no location specified)
Aug 14, 2023
Intestinal Microbiome in Wet Age-related Macular Degeneration
Recruiting
- Age-Related Macular Degeneration
- Sample examination
-
Ioánnina, Epirus, Greece
- +1 more
Feb 23, 2023
Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)
Recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept 40 MG/ML
- Faricimab 120 MG/ML
-
Graz, Styria, AustriaDepartment of Ophthalmolgy, Medical University Graz
Jul 3, 2023
Single Injection of Faricimab for nAMD With Persisting Fluid
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Glostrup, DenmarkMiklos Schneider
Nov 3, 2023
Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept Ophthalmic
- IBI302
-
Suzhou, Jiangsu, ChinaInnovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023
Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])
Not yet recruiting
- Age-related Wet Macular Degeneration
- CG-P5 peptide
- +2 more
-
Augusta, Georgia
- +3 more
Nov 13, 2023
Rehabilitating Vision Loss in Veterans With Age-Related Macular
Not yet recruiting
- Age-related Macular Degeneration (AMD)
- Study-specific rehabilitation (SSR) procedures
-
Augusta, GeorgiaCharlie Norwood VA Medical Center, Augusta, GA
Mar 10, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Austin, TexasRetina Consultants of Austin
Jan 16, 2023
Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)
Not yet recruiting
- Age-Related Macular Degeneration
- NG101 AAV gene therapy
-
Toronto, Ontario, CanadaVitreous Retina Macula Specialists of Toronto
Aug 2, 2023
Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)
Recruiting
- Neovascular Age-related Macular Degeneration
-
Phoenix, ArizonaRetinal Research Institute, LLC
Jun 4, 2023
Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)
Not yet recruiting
- Diabetic Macular Edema (DME)
- Neovascular Age-Related Macular Degeneration (nAMD)
- aflibercept 8 mg PFS
- (no location specified)
Aug 3, 2023
Neovascular Age-related Macular Degeneration Trial (RRG001)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- (no location specified)
Nov 15, 2023
Impact of Non-Exudative Type 1 MNV on AMD Progression
Recruiting
- Age-Related Macular Degeneration
- Neovascularization, Choroidal
-
Salt Lake City, UtahUniversity of Utah
Nov 15, 2023
Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- AR-14034 SR implant lower dose
- +3 more
- (no location specified)
Mar 3, 2023
Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)
Recruiting
- Age-Related Macular Degeneration
- VOY-101
-
Sydney, New South Wales, Australia
- +3 more
Oct 17, 2023
Macular Degeneration, Retinal Degeneration, Retinal Diseases Trial in Boston (Pistachio Group)
Recruiting
- Macular Degeneration
- +3 more
- Pistachio Group
-
Boston, MassachusettsClinical and Translational Research Center (CTRC) - Tufts
Jun 9, 2022